Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Takeda goes back to school, teaming up with Discovery Education for health equity initiative
3 years ago
Marketing
Biggest drug companies halted Twitter ad buys after Lilly insulin spoof
3 years ago
Marketing
Rare in common: Health Union's newest social community aims to connect across rare diseases
3 years ago
Marketing
Merck KGaA spotlights need for deals to shake up R&D, with external partners key to new drugs
3 years ago
Updated: No Seagen here: 'Do more' means a small $1.35B purchase of Imago for Merck
3 years ago
Deals
ViiV takes to the couch for conversations about HIV in its new ‘Science on the Sofa’ series
3 years ago
Marketing
CDC survey reveals Covid-19 vaccination rates for children remain low
3 years ago
Coronavirus
Congress takes another look at reclassifying psilocybin and MDMA
3 years ago
Beyond the IRA: Research points to need for even lower copay caps for some Part D beneficiaries
3 years ago
Pfizer and BioNTech roll out new data for their bivalent booster against newer Omicron variants
3 years ago
R&D
Coronavirus
Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
3 years ago
FDA+
Lilly wins FDA approval for second interchangeable insulin biosimilar
3 years ago
FDA+
Pharma foe Bernie Sanders to take over leadership of Senate health committee
3 years ago
Law
Vanda appeals to FDA again, insisting on sNDA hearing in latest wrinkle in jet lag drug saga
3 years ago
Predictive marketing moves into electronic health records, targeting doctors at exact points of care
3 years ago
Marketing
GSK once again tops drug accessibility ranking, with J&J and AstraZeneca close behind
3 years ago
Marketing
Radioisotope company moves forward with CDMO plans, breaking ground on new manufacturing site in Wisconsin
3 years ago
Manufacturing
Updated: In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions
3 years ago
FDA+
Novartis considers selling its $5B+ ophthalmology and respiratory units — report
3 years ago
More than 150 industry groups urge Congress to act on antimicrobial resistance
3 years ago
Merck KGaA’s MilliporeSigma invests $286M to build out biosafety testing
3 years ago
Manufacturing
Top PBM to put Humira biosimilars on level playing field with AbbVie blockbuster
3 years ago
UK cost watchdog drafts guidance against 5 Covid treatments and J&J depression med
3 years ago
FDA+
Coronavirus
Ecommerce marketing for pharma? Agency adds new specialty unit with eye to future
3 years ago
Marketing
First page
Previous page
160
161
162
163
164
165
166
Next page
Last page